Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Late gadolinium enhancement on cardiac magnetic resonance imaging is associated with coronary endothelial dysfunction in patients with dilated cardiomyopathy.
Nakayama M, Yamamuro M, Takashio S, Uemura T, Nakayama N, Hirakawa K, Oda S, Utsunomiya D, Kaikita K, Hokimoto S, Yamashita Y, Morita Y, Kimura K, Tamura K, Tsujita K. Nakayama M, et al. Among authors: hokimoto s. Heart Vessels. 2018 Apr;33(4):393-402. doi: 10.1007/s00380-017-1069-1. Epub 2017 Oct 19. Heart Vessels. 2018. PMID: 29051976
Prognostic value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen levels in patients with coronary artery disease.
Miura M, Kaikita K, Matsukawa M, Soejima K, Fuchigami S, Miyazaki Y, Ono T, Uemura T, Tsujita K, Hokimoto S, Sumida H, Sugiyama S, Matsui K, Yamabe H, Ogawa H. Miura M, et al. Among authors: hokimoto s. Thromb Haemost. 2010 Mar;103(3):623-9. doi: 10.1160/TH09-08-0568. Epub 2010 Feb 2. Thromb Haemost. 2010. PMID: 20135067
Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy.
Yamamoto K, Hokimoto S, Chitose T, Morita K, Ono T, Kaikita K, Tsujita K, Abe T, Deguchi M, Miyagawa H, Saruwatari J, Sumida H, Sugiyama S, Nakagawa K, Ogawa H. Yamamoto K, et al. Among authors: hokimoto s. J Cardiol. 2011 Mar;57(2):194-201. doi: 10.1016/j.jjcc.2010.10.007. Epub 2010 Dec 17. J Cardiol. 2011. PMID: 21168310 Free article.
Determination of cut-off levels for on-clopidogrel platelet aggregation based on functional CYP2C19 gene variants in patients undergoing elective percutaneous coronary intervention.
Ono T, Kaikita K, Hokimoto S, Iwashita S, Yamamoto K, Miyazaki Y, Horio E, Sato K, Tsujita K, Abe T, Deguchi M, Tayama S, Sumida H, Sugiyama S, Yamabe H, Nakamura S, Nakagawa K, Ogawa H. Ono T, et al. Among authors: hokimoto s. Thromb Res. 2011 Dec;128(6):e130-6. doi: 10.1016/j.thromres.2011.07.028. Epub 2011 Aug 20. Thromb Res. 2011. PMID: 21862109
Clinical outcomes following coronary stenting in Japanese patients treated with and without proton pump inhibitor.
Chitose T, Hokimoto S, Oshima S, Nakao K, Fujimoto K, Miyao Y, Shimomura H, Tsunoda R, Maruyama H, Hirose T, Yamamoto K, Mizobe M, Kaikita K, Nakamura S, Ogawa H; Kumamoto Intervention Conference Study (KICS) Investigators. Chitose T, et al. Among authors: hokimoto s. Circ J. 2012;76(1):71-8. doi: 10.1253/circj.cj-11-0699. Epub 2011 Dec 1. Circ J. 2012. PMID: 22130313 Free article.
233 results